Skip to main content

This job has expired

You will need to login before you can apply for a job.

Associate Director/Director, New Product Planning (NPP)

Employer
Nurix Therapeutics
Location
San Francisco, CA, United States
Start date
Dec 18, 2020

View more

Job Details

This position offers a candidate the opportunity to significantly contribute to the long-term commercial success of the portfolio, and is responsible for providing commercial assessments of key early stage product planning opportunities, market research activities, lifecycle planning, competitive positioning and preferred product presentation.

Key Responsibilities
  • Support and participate in the development of forward-looking strategies, market positioning and product profiles for Autoimmune and Oncology pipeline products by synthesizing primary and secondary inputs that will inform the development and lifecycle plan
  • Drive completion of NPP and market research initiatives and work closely with the project teams to track key milestone progress across pipeline programs
  • Serve as an active member of product teams in the early stage development of the Autoimmune and Oncology portfolio ensuring strategic commercial insight with internal business partners (research, clinical, CMC, etc) to optimize the market value of assets
  • Manage external consulting partners (e.g., strategy consultants, market research) to update commercial assessment tool(s) as needed and proactively seek out ways to improve assessments
  • Track, understand, and communicate the therapeutic market trends across multiple perspectives (e.g. commercial, managed markets, clinical, and scientific)
  • Proactively monitor and evaluate market developments and changes in competitive landscape for key therapeutic areas/markets
  • Provide early market assessments and develop value proposition, business cases and early forecasts to prioritize commercial indications for products in key therapeutic areas
  • Manage assigned budget

Basic Requirements and Education
  • Bachelor's degree or equivalent, advanced degree (MBA) a plus
  • Background or degree in science a plus
  • Minimum of 8-10 years' experience in commercial roles, e.g. NPP, specialty pharmaceutical marketing, market research; 3 – 5 years of oncology and/or autoimmune brand marketing and product launch experience preferred
  • Previous experience in a commercial assessment role that required comprehensive understanding of therapeutic markets from multiple customer perspectives (e.g., HCP, Payers, Patients) and/or different business perspectives (e.g., clinical, R&D, marketing)
  • Strong understanding of managed care, access, regulatory and pricing dynamics

Preferred Skills and Knowledge Requirements
  • Significant analytic skills, able to clearly interpret and distill scientific, clinical and commercial information
    • Basic understanding of key marketing and market research principles
    • Familiarity with secondary research and databases
  • Ability to effectively plan, prioritize, execute, follow up and anticipate challenges
  • Ability to work, influence, and gain consensus across multiple functions (e.g. research, clinical, regulatory, translational medicine)
  • Excellent organization, communication (written and oral) and facilitation skills
  • Self-motivated, builds trust easily and operates with integrity and ethics
  • Demonstrated learning agility
  • Strong history of delivering high quality, sustainable results using skills and capabilities

Company

Nurix Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. Leveraging Nurix’s extensive expertise in E3 ligases together with its proprietary DNA-encoded libraries, Nurix has built DELigase, an integrated discovery platform to identify and advance novel drug candidates targeting E3 ligases, a broad class of enzymes that can modulate proteins within the cell. Nurix’s drug discovery approach is to either harness or inhibit the natural function of E3 ligases within the ubiquitin proteasome system to selectively decrease or increase cellular protein levels.

Nurix’s wholly owned pipeline comprises targeted protein degraders of Bruton’s tyrosine kinase, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, an E3 ligase that regulates T cell activation. Nurix is headquartered in San Francisco, California.

Company info
Website
Phone
415-660-5320
Location
1700 Owens Street
Suite 205
San Francisco
California
94158
US

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert